mTOR aggravated CD4++ T cell pyroptosis by regulating the PPARγ-Nrf2 γ-Nrf2 pathway in sepsis

被引:1
|
作者
Zhao, Guoyu [1 ]
Xie, Yawen [1 ]
Lei, Xianli [1 ]
Guo, Ran [1 ]
Cui, Na [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Dept Crit Care Med, Beijing 100730, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
mTOR; Pyroptosis; PPAR gamma; Nrf2; Sepsis; CD4+T cell; INDUCED IMMUNOSUPPRESSION; ACTIVATION;
D O I
10.1016/j.intimp.2024.112822
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a systemic inflammatory response syndrome caused by a dysregulated host response to infection. CD4+T + T cell reduction is crucial to sepsis-induced immunosuppression. Pyroptosis, a programmed necrosis, is concerned with lymphocytopenia. Peroxisome proliferator-activated receptor gamma (PPAR gamma) regulated by upstream mTOR, exerts anti-pyroptosis effects. To investigate the potential effects of mTOR-PPAR gamma on sepsis-induced CD4+T + T cell depletion and the underlying mechanisms, we observed mTOR activation and pyroptosis with PPAR gamma-Nrf suppression through cecal ligation and puncture (CLP) sepsis mouse model. Further mechanism research used genetically modified mice with T cell-specific knockout mTOR or Tuberous Sclerosis Complex1 (TSC1). It revealed that mTOR mediated CD4 + T cell pyroptosis in septic mice by negatively regulating the PPAR gamma-Nrf2 signaling pathway. Taken together, mTOR-PPAR gamma-Nrf2 signaling mediated the CD4+ + T cell pyroptosis in sepsis, contributing to CD4+T + T cell depletion and immunosuppression.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] mTOR aggravated CD4+ T cell pyroptosis by regulating the PPARγ-Nrf2 pathway in sepsis (vol 140, 112822, 2024)
    Zhao, Guoyu
    Xie, Yawen
    Lei, Xianli
    Guo, Ran
    Cui, Na
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [2] Mitochondria, Nrf2 and mTOR
    Cortopassi, Gino
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 128 : S7 - S7
  • [3] Quercetin Inhibits Pyroptosis in Diabetic Cardiomyopathy through the Nrf2 Pathway
    Zhang, Wei
    Zhou, Jing
    Kang, Pinfang
    Shi, Chao
    Qian, Shaohuan
    JOURNAL OF DIABETES RESEARCH, 2022, 2022
  • [4] The Nrf2 Pathway in Liver Diseases
    Zhou, Jiaming
    Zheng, Qiuxian
    Chen, Zhi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [5] Nrf2 - A novel regulator of sepsis.
    Biswal, S
    Thimmulappa, RK
    Yamamoto, M
    Kensler, TW
    SHOCK, 2005, 23 : 10 - 10
  • [6] Activation, interaction and intimation of Nrf2 pathway and their mutational studies causing Nrf2 associated cancer
    Sahu, Mridul
    Jain, Utkarsh
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [7] The Role of Nrf2 in Primary Human CD4 T Cell Activation and Differentiation
    Turley, Alexandra E.
    Zagorski, Joseph
    Rockwell, Cheryl E.
    FASEB JOURNAL, 2017, 31
  • [8] Tethering of Nrf2 to Keap1 prevents Nrf2 degradation by the ubiquitin proteasome pathway
    Sekhar, K
    Yan, X
    Freeman, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S350 - S351
  • [9] Chitosan oligosaccharides alleviate macrophage pyroptosis and protect sepsis mice via activating the Nrf2/GPX4 pathway
    Lu, Zhong-Xia
    Liu, Lu-Xin
    Fu, Zheng
    Wang, Sheng-Nan
    Sun, Chang-Ning
    Yu, Wen-Gong
    Lu, Xin-Zhi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277
  • [10] Diosgenin inhibited podocyte pyroptosis in diabetic kidney disease by regulating the Nrf2/NLRP3 pathway
    Tang, Yu
    Hu, Wenxiao
    Peng, Yajun
    Ling, Xiangdong
    BIOCELL, 2024, 48 (10)